logo
Plus   Neg
Share
Email

Novartis : Type 2 Diabetes Study Shows Long-term Clinical Benefits

Novartis (NVS) said that five-year VERIFY study in type 2 diabetes demonstrated long-term clinical benefits of early combination treatment with Galvus and metformin.

The company noted that early combination treatment strategy with vildagliptin (Galvus) and metformin was superior to standard of care in newly diagnosed type 2 diabetes patients.

The company said it is committed to optimizing patient management of type 2 diabetes to achieve better glycemic control and favorable long-term clinical outcomes.

Additional pre-defined secondary analyses of the VERIFY study results are ongoing and data will be disclosed over the coming months at international and local medical congresses and in scientific journals, the company said.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Ride hailing company Uber Technologies Inc. is cutting 600 jobs in India amid the impact of continuing coronavirus-related lockdown across the country, reports said citing Uber India and South Asia President Pradeep Parameswaran. The affected employees include full-time workers in driver and rider support, as well as other functions, and represent around 25 percen of its workforce in the country. Conagra Brands, Inc. is recalling approximately 276,872 pounds of not ready-to-eat chicken and turkey bowl products, citing the presence of extraneous materials specifically small rocks, the U.S. Department of Agriculture's Food Safety and Inspection Service or FSIS announced in a statement. The latest recall is an expansion to the Russellville, Arkansas-based company's earlier recall in April. The German government has approved a 9 billion euros rescue package for Deutsche Lufthansa AG (DLAKF, DLAKY), which is the largest German corporate rescue package since the coronavirus crisis struck. The airline has also agreed to the rescue deal.
Follow RTT